Key result
Continuous HRV biofeedback with health coaching increases baseline HRV ~38% in ME/CFS.
Why the study?
Little research exists on using continuous HRV tracking versus baseline HRV and HR monitoring as a pacing and autonomic nervous system management tool in myalgic encephalomyelitis/chronic fatigue syndrome.
Does continuous ECG-grade HRV biofeedback tracking combined with expert analysis and health coaching improve autonomic nervous system regulation and functional capacity in a patient experiencing a severe ME/CFS relapse?
Case Report (n=1)
Open-label
No
Does continuous ECG-grade HRV biofeedback tracking combined with expert analysis and health coaching improve autonomic nervous system regulation and functional capacity in a patient experiencing a severe ME/CFS relapse?
Continuous ECG-grade HRV biofeedback combined with health coaching improved autonomic regulation (37.5% increase in RMSSD) and subjective wellbeing over 11 weeks in a patient with severe ME/CFS relapse, while revealing a 48-hour delayed HRV drop during immune flares compared to immediate drops before exertion-induced PEM.
Answers are grounded in this paper and cite their sources.
May support HRV biofeedback in ME/CFS relapse; leaves open confirmation in controlled trials.
Background: Myalgic Encephalomyelitis (ME/CFS), is a long-term, multi system disease characterised by profound, unrefreshing fatigue, pain, cognitive dysfunction, and post exertional malaise (PEM). Heart rate variability (HRV) measures the variation in time intervals between heartbeats to provide an objective indicator of autonomic nervous system (ANS) regulation and resilience. HRV tracking is used to assess autonomic dysfunction in ME/CFS and hypothesised to serve as an early warning system for predicting PEM and prioritising rest. To date there is little research on the use of continuous HRV (C-HRV) tracking, versus baseline HRV and HR monitoring as a pacing and ANS management tool. This case reports a 63 year old female with a 7 year history of stable ME/CFS who experienced a severe symptomatic relapse following a period of physical and psychosocial stress. The patient’s primary concerns were reduced functional capacity, frequent PEM and immune system flares. Method: The subject used real time C-HRV tracking using an electrocardiogram (ECG) grade Firstbeat Life device and engaged in regular health coaching with an HRV trained coach for lifestyle support and HRV data interpretation. The aim of this study was to assess the effectiveness of C-HRV tracking with expert HRV analysis for understanding and improving ANS regulation to help manage energy, and improve functional capacity. Results : Over the 11-week intervention, C-HRV biofeedback showed enhanced ANS regulation, increased baseline HRV, and improvements in perceived cognitive stability and energy. The patient improved her autonomic awareness, PEM predictability, identification of recovery barriers, and effectiveness of specific ANS strategies. A key finding was a lagging HRV response during immune system flares, despite immediate flu-like symptoms, which aligns with established neuroimmune models. This suggests HRV’s role as an early warning system is state and system dependent, and the ANS and immune system may generate different HRV responses.
No takes yet. Share an insight, caveat, or question.
Duder et al. (2026) conducted a case report in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) relapse (n=1). Continuous heart rate variability (C-HRV) biofeedback tracking (Firstbeat Life ECG device) with specialist HRV analysis and health coaching vs. Baseline (Month 1 pre-intervention metrics) was evaluated on Baseline heart rate variability (RMSSD in ms). Continuous HRV biofeedback with health coaching increased baseline HRV (RMSSD) by 37.5% (from 24 ms to 33 ms) and doubled stress-recovery balance scores over 11 weeks in a patient with ME/CFS relapse.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: